Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of BR-UPS vs Inisia in Healthy Female Volunteers
NCT03156127Phase 1Withdrawn
- Sponsor
- Boryung
- Start
- May 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ulipristal in uterine fibroid (2 arms), sponsored by Boryung. Primary endpoints: Maximum concentration of drug in plasma and Area under the plasma drug concentration-time curve from 0 to last quantifiable concentration. Planned start May 2017; status: withdrawn.
02
Drugs
ulipristal
03
Conditions
uterine fibroid
Beyond the preview
Go deeper on NCT03156127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03156127.